Europe Human Coagulation Factor VIII Market Report 2017

January 2017 | 106 pages | ID: EB3EDDA2C5EEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Human Coagulation Factor VIII

Revenue, means the sales value of Human Coagulation Factor VIII

This report studies sales (consumption) of Human Coagulation Factor VIII in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Baxter
• Bayer
• Pfizer
• CSL Behring
• Grifols
• Octapharma
• BPL
• Kedrion

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Human Coagulation Factor VIII in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Recombinant Factor VIII
• Plasma-derived Factor VIII

Split by application, this report focuses on sales, market share and growth rate of Human Coagulation Factor VIII in each application, can be divided into

• Hemophilia A
• Spontanous + Traum
• Surgical

Contents

Europe Human Coagulation Factor VIII Market Report 2017

1 HUMAN COAGULATION FACTOR VIII OVERVIEW

1.1 Product Overview and Scope of Human Coagulation Factor VIII
1.2 Classification of Human Coagulation Factor VIII
  1.2.1 Recombinant Factor VIII
  1.2.2 Plasma-derived Factor VIII
1.3 Application of Human Coagulation Factor VIII
  1.3.1 Hemophilia A
  1.3.2 Spontanous + Traum
  1.3.3 Surgical
1.4 Human Coagulation Factor VIII Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Human Coagulation Factor VIII (2011-2021)
  1.5.1 Europe Human Coagulation Factor VIII Sales and Growth Rate (2011-2021)
  1.5.2 Europe Human Coagulation Factor VIII Revenue and Growth Rate (2011-2021)

2 EUROPE HUMAN COAGULATION FACTOR VIII BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Human Coagulation Factor VIII Market Competition by Manufacturers
  2.1.1 Europe Human Coagulation Factor VIII Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Human Coagulation Factor VIII Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Human Coagulation Factor VIII (Volume and Value) by Type
  2.2.1 Europe Human Coagulation Factor VIII Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Human Coagulation Factor VIII Revenue and Market Share by Type (2011-2016)
2.3 Europe Human Coagulation Factor VIII (Volume and Value) by Countries
  2.3.1 Europe Human Coagulation Factor VIII Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Human Coagulation Factor VIII Revenue and Market Share by Countries (2011-2016)
2.4 Europe Human Coagulation Factor VIII (Volume) by Application

3 GERMANY HUMAN COAGULATION FACTOR VIII (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Human Coagulation Factor VIII Sales and Value (2011-2016)
  3.1.1 Germany Human Coagulation Factor VIII Sales and Growth Rate (2011-2016)
  3.1.2 Germany Human Coagulation Factor VIII Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Human Coagulation Factor VIII Sales Price Trend (2011-2016)
3.2 Germany Human Coagulation Factor VIII Sales and Market Share by Manufacturers
3.3 Germany Human Coagulation Factor VIII Sales and Market Share by Type
3.4 Germany Human Coagulation Factor VIII Sales and Market Share by Application

4 FRANCE HUMAN COAGULATION FACTOR VIII (VOLUME, VALUE AND SALES PRICE)

4.1 France Human Coagulation Factor VIII Sales and Value (2011-2016)
  4.1.1 France Human Coagulation Factor VIII Sales and Growth Rate (2011-2016)
  4.1.2 France Human Coagulation Factor VIII Revenue and Growth Rate (2011-2016)
  4.1.4 France Human Coagulation Factor VIII Sales Price Trend (2011-2016)
4.2 France Human Coagulation Factor VIII Sales and Market Share by Manufacturers
4.3 France Human Coagulation Factor VIII Sales and Market Share by Type
4.4 France Human Coagulation Factor VIII Sales and Market Share by Application

5 UK HUMAN COAGULATION FACTOR VIII (VOLUME, VALUE AND SALES PRICE)

5.1 UK Human Coagulation Factor VIII Sales and Value (2011-2016)
  5.1.1 UK Human Coagulation Factor VIII Sales and Growth Rate (2011-2016)
  5.1.2 UK Human Coagulation Factor VIII Revenue and Growth Rate (2011-2016)
  5.1.5 UK Human Coagulation Factor VIII Sales Price Trend (2011-2016)
5.2 UK Human Coagulation Factor VIII Sales and Market Share by Manufacturers
5.3 UK Human Coagulation Factor VIII Sales and Market Share by Type
5.4 UK Human Coagulation Factor VIII Sales and Market Share by Application

6 RUSSIA HUMAN COAGULATION FACTOR VIII (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Human Coagulation Factor VIII Sales and Value (2011-2016)
  6.1.1 Russia Human Coagulation Factor VIII Sales and Growth Rate (2011-2016)
  6.1.2 Russia Human Coagulation Factor VIII Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Human Coagulation Factor VIII Sales Price Trend (2011-2016)
6.2 Russia Human Coagulation Factor VIII Sales and Market Share by Manufacturers
6.3 Russia Human Coagulation Factor VIII Sales and Market Share by Type
6.4 Russia Human Coagulation Factor VIII Sales and Market Share by Application

7 ITALY HUMAN COAGULATION FACTOR VIII (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Human Coagulation Factor VIII Sales and Value (2011-2016)
  7.1.1 Italy Human Coagulation Factor VIII Sales and Growth Rate (2011-2016)
  7.1.2 Italy Human Coagulation Factor VIII Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Human Coagulation Factor VIII Sales Price Trend (2011-2016)
7.2 Italy Human Coagulation Factor VIII Sales and Market Share by Manufacturers
7.3 Italy Human Coagulation Factor VIII Sales and Market Share by Type
7.4 Italy Human Coagulation Factor VIII Sales and Market Share by Application

8 SPAIN HUMAN COAGULATION FACTOR VIII (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Human Coagulation Factor VIII Sales and Value (2011-2016)
  8.1.1 Spain Human Coagulation Factor VIII Sales and Growth Rate (2011-2016)
  8.1.2 Spain Human Coagulation Factor VIII Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Human Coagulation Factor VIII Sales Price Trend (2011-2016)
8.2 Spain Human Coagulation Factor VIII Sales and Market Share by Manufacturers
8.3 Spain Human Coagulation Factor VIII Sales and Market Share by Type
8.4 Spain Human Coagulation Factor VIII Sales and Market Share by Application

9 BENELUX HUMAN COAGULATION FACTOR VIII (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Human Coagulation Factor VIII Sales and Value (2011-2016)
  9.1.1 Benelux Human Coagulation Factor VIII Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Human Coagulation Factor VIII Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Human Coagulation Factor VIII Sales Price Trend (2011-2016)
9.2 Benelux Human Coagulation Factor VIII Sales and Market Share by Manufacturers
9.3 Benelux Human Coagulation Factor VIII Sales and Market Share by Type
9.4 Benelux Human Coagulation Factor VIII Sales and Market Share by Application

10 EUROPE HUMAN COAGULATION FACTOR VIII MANUFACTURERS ANALYSIS

10.1 Baxter
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Human Coagulation Factor VIII Product Type, Application and Specification
    10.1.2.1 Recombinant Factor VIII
    10.1.2.2 Plasma-derived Factor VIII
  10.1.3 Baxter Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Bayer
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Human Coagulation Factor VIII Product Type, Application and Specification
    10.2.2.1 Recombinant Factor VIII
    10.2.2.2 Plasma-derived Factor VIII
  10.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Pfizer
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Human Coagulation Factor VIII Product Type, Application and Specification
    10.3.2.1 Recombinant Factor VIII
    10.3.2.2 Plasma-derived Factor VIII
  10.3.3 Pfizer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 CSL Behring
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Human Coagulation Factor VIII Product Type, Application and Specification
    10.4.2.1 Recombinant Factor VIII
    10.4.2.2 Plasma-derived Factor VIII
  10.4.3 CSL Behring Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Grifols
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Human Coagulation Factor VIII Product Type, Application and Specification
    10.5.2.1 Recombinant Factor VIII
    10.5.2.2 Plasma-derived Factor VIII
  10.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Octapharma
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Human Coagulation Factor VIII Product Type, Application and Specification
    10.6.2.1 Recombinant Factor VIII
    10.6.2.2 Plasma-derived Factor VIII
  10.6.3 Octapharma Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 BPL
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Human Coagulation Factor VIII Product Type, Application and Specification
    10.7.2.1 Recombinant Factor VIII
    10.7.2.2 Plasma-derived Factor VIII
  10.7.3 BPL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Kedrion
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Human Coagulation Factor VIII Product Type, Application and Specification
    10.8.2.1 Recombinant Factor VIII
    10.8.2.2 Plasma-derived Factor VIII
  10.8.3 Kedrion Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview

11 HUMAN COAGULATION FACTOR VIII MANUFACTURING COST ANALYSIS

11.1 Human Coagulation Factor VIII Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Human Coagulation Factor VIII

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Human Coagulation Factor VIII Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Human Coagulation Factor VIII Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE HUMAN COAGULATION FACTOR VIII MARKET FORECAST (2016-2021)

14.1 Germany Human Coagulation Factor VIII Sales Forecast (2016-2021)
14.2 France Human Coagulation Factor VIII Sales Forecast (2016-2021)
14.3 UK Human Coagulation Factor VIII Sales Forecast (2016-2021)
14.4 Russia Human Coagulation Factor VIII Sales Forecast (2016-2021)
14.5 Italy Human Coagulation Factor VIII Sales Forecast (2016-2021)
14.6 Spain Human Coagulation Factor VIII Sales Forecast (2016-2021)
14.7 Benelux Human Coagulation Factor VIII Sales Forecast (2016-2021)
14.8 Europe Human Coagulation Factor VIII Sales Forecast by Type (2016-2021)
14.9 Europe Human Coagulation Factor VIII Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Human Coagulation Factor VIII
Table Classification of Human Coagulation Factor VIII
Figure Europe Sales Market Share of Human Coagulation Factor VIII by Type in 2015
Figure Recombinant Factor VIII Picture
Figure Plasma-derived Factor VIII Picture
Table Application of Human Coagulation Factor VIII
Figure Europe Sales Market Share of Human Coagulation Factor VIII by Application in 2015
Figure Hemophilia A Examples
Figure Spontanous + Traum Examples
Figure Surgical Examples
Figure Germany Human Coagulation Factor VIII Revenue and Growth Rate (2011-2021)
Figure France Human Coagulation Factor VIII Revenue and Growth Rate (2011-2021)
Figure UK Human Coagulation Factor VIII Revenue and Growth Rate (2011-2021)
Figure Russia Human Coagulation Factor VIII Revenue and Growth Rate (2011-2021)
Figure Italy Human Coagulation Factor VIII Revenue and Growth Rate (2011-2021)
Figure Spain Human Coagulation Factor VIII Revenue and Growth Rate (2011-2021)
Figure Benelux Human Coagulation Factor VIII Revenue and Growth Rate (2011-2021)
Figure Europe Human Coagulation Factor VIII Sales and Growth Rate (2011-2021)
Figure Europe Human Coagulation Factor VIII Revenue and Growth Rate (2011-2021)
Table Europe Human Coagulation Factor VIII Sales of Key Manufacturers (2015 and 2016)
Table Europe Human Coagulation Factor VIII Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Human Coagulation Factor VIII Sales Share by Manufacturers
Figure 2016 Human Coagulation Factor VIII Sales Share by Manufacturers
Table Europe Human Coagulation Factor VIII Revenue by Manufacturers (2015 and 2016)
Table Europe Human Coagulation Factor VIII Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Human Coagulation Factor VIII Revenue Share by Manufacturers
Table 2016 Europe Human Coagulation Factor VIII Revenue Share by Manufacturers
Table Europe Human Coagulation Factor VIII Sales and Market Share by Type (2011-2016)
Table Europe Human Coagulation Factor VIII Sales Share by Type (2011-2016)
Figure Sales Market Share of Human Coagulation Factor VIII by Type (2011-2016)
Figure Europe Human Coagulation Factor VIII Sales Growth Rate by Type (2011-2016)
Table Europe Human Coagulation Factor VIII Revenue and Market Share by Type (2011-2016)
Table Europe Human Coagulation Factor VIII Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Human Coagulation Factor VIII by Type (2011-2016)
Figure Europe Human Coagulation Factor VIII Revenue Growth Rate by Type (2011-2016)
Table Europe Human Coagulation Factor VIII Sales and Market Share by Countries (2011-2016)
Table Europe Human Coagulation Factor VIII Sales Share by Countries (2011-2016)
Figure Sales Market Share of Human Coagulation Factor VIII by Countries (2011-2016)
Table Europe Human Coagulation Factor VIII Revenue and Market Share by Countries (2011-2016)
Table Europe Human Coagulation Factor VIII Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Human Coagulation Factor VIII by Countries (2011-2016)
Table Europe Human Coagulation Factor VIII Sales and Market Share by Application (2011-2016)
Table Europe Human Coagulation Factor VIII Sales Share by Application (2011-2016)
Figure Sales Market Share of Human Coagulation Factor VIII by Application (2011-2016)
Figure Germany Human Coagulation Factor VIII Sales and Growth Rate (2011-2016)
Figure Germany Human Coagulation Factor VIII Revenue and Growth Rate (2011-2016)
Figure Germany Human Coagulation Factor VIII Sales Price Trend (2011-2016)
Table Germany Human Coagulation Factor VIII Sales by Manufacturers (2015 and 2016)
Table Germany Human Coagulation Factor VIII Market Share by Manufacturers (2015 and 2016)
Table Germany Human Coagulation Factor VIII Sales by Type (2015 and 2016)
Table Germany Human Coagulation Factor VIII Market Share by Type (2015 and 2016)
Table Germany Human Coagulation Factor VIII Sales by Application (2015 and 2016)
Table Germany Human Coagulation Factor VIII Market Share by Application (2015 and 2016)
Figure France Human Coagulation Factor VIII Sales and Growth Rate (2011-2016)
Figure France Human Coagulation Factor VIII Revenue and Growth Rate (2011-2016)
Figure France Human Coagulation Factor VIII Sales Price Trend (2011-2016)
Table France Human Coagulation Factor VIII Sales by Manufacturers (2015 and 2016)
Table France Human Coagulation Factor VIII Market Share by Manufacturers (2015 and 2016)
Table France Human Coagulation Factor VIII Sales by Type (2015 and 2016)
Table France Human Coagulation Factor VIII Market Share by Type (2015 and 2016)
Table France Human Coagulation Factor VIII Sales by Application (2015 and 2016)
Table France Human Coagulation Factor VIII Market Share by Application (2015 and 2016)
Figure UK Human Coagulation Factor VIII Sales and Growth Rate (2011-2016)
Figure UK Human Coagulation Factor VIII Revenue and Growth Rate (2011-2016)
Figure UK Human Coagulation Factor VIII Sales Price Trend (2011-2016)
Table UK Human Coagulation Factor VIII Sales by Manufacturers (2015 and 2016)
Table UK Human Coagulation Factor VIII Market Share by Manufacturers (2015 and 2016)
Table UK Human Coagulation Factor VIII Sales by Type (2015 and 2016)
Table UK Human Coagulation Factor VIII Market Share by Type (2015 and 2016)
Table UK Human Coagulation Factor VIII Sales by Application (2015 and 2016)
Table UK Human Coagulation Factor VIII Market Share by Application (2015 and 2016)
Figure Russia Human Coagulation Factor VIII Sales and Growth Rate (2011-2016)
Figure Russia Human Coagulation Factor VIII Revenue and Growth Rate (2011-2016)
Figure Russia Human Coagulation Factor VIII Sales Price Trend (2011-2016)
Table Russia Human Coagulation Factor VIII Sales by Manufacturers (2015 and 2016)
Table Russia Human Coagulation Factor VIII Market Share by Manufacturers (2015 and 2016)
Table Russia Human Coagulation Factor VIII Sales by Type (2015 and 2016)
Table Russia Human Coagulation Factor VIII Market Share by Type (2015 and 2016)
Table Russia Human Coagulation Factor VIII Sales by Application (2015 and 2016)
Table Russia Human Coagulation Factor VIII Market Share by Application (2015 and 2016)
Figure Italy Human Coagulation Factor VIII Sales and Growth Rate (2011-2016)
Figure Italy Human Coagulation Factor VIII Revenue and Growth Rate (2011-2016)
Figure Italy Human Coagulation Factor VIII Sales Price Trend (2011-2016)
Table Italy Human Coagulation Factor VIII Sales by Manufacturers (2015 and 2016)
Table Italy Human Coagulation Factor VIII Market Share by Manufacturers (2015 and 2016)
Table Italy Human Coagulation Factor VIII Sales by Type (2015 and 2016)
Table Italy Human Coagulation Factor VIII Market Share by Type (2015 and 2016)
Table Italy Human Coagulation Factor VIII Sales by Application (2015 and 2016)
Table Italy Human Coagulation Factor VIII Market Share by Application (2015 and 2016)
Figure Spain Human Coagulation Factor VIII Sales and Growth Rate (2011-2016)
Figure Spain Human Coagulation Factor VIII Revenue and Growth Rate (2011-2016)
Figure Spain Human Coagulation Factor VIII Sales Price Trend (2011-2016)
Table Spain Human Coagulation Factor VIII Sales by Manufacturers (2015 and 2016)
Table Spain Human Coagulation Factor VIII Market Share by Manufacturers (2015 and 2016)
Table Spain Human Coagulation Factor VIII Sales by Type (2015 and 2016)
Table Spain Human Coagulation Factor VIII Market Share by Type (2015 and 2016)
Table Spain Human Coagulation Factor VIII Sales by Application (2015 and 2016)
Table Spain Human Coagulation Factor VIII Market Share by Application (2015 and 2016)
Figure Benelux Human Coagulation Factor VIII Sales and Growth Rate (2011-2016)
Figure Benelux Human Coagulation Factor VIII Revenue and Growth Rate (2011-2016)
Figure Benelux Human Coagulation Factor VIII Sales Price Trend (2011-2016)
Table Benelux Human Coagulation Factor VIII Sales by Manufacturers (2015 and 2016)
Table Benelux Human Coagulation Factor VIII Market Share by Manufacturers (2015 and 2016)
Table Benelux Human Coagulation Factor VIII Sales by Type (2015 and 2016)
Table Benelux Human Coagulation Factor VIII Market Share by Type (2015 and 2016)
Table Benelux Human Coagulation Factor VIII Sales by Application (2015 and 2016)
Table Benelux Human Coagulation Factor VIII Market Share by Application (2015 and 2016)
Table Human Coagulation Factor VIII Basic Information List
Table Baxter Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Baxter Human Coagulation Factor VIII Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Human Coagulation Factor VIII Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Human Coagulation Factor VIII Sales Market Share (2011-2016)
Table CSL Behring Basic Information List
Table CSL Behring Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table CSL Behring Human Coagulation Factor VIII Sales Market Share (2011-2016)
Table Grifols Basic Information List
Table Grifols Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Grifols Human Coagulation Factor VIII Sales Market Share (2011-2016)
Table Octapharma Basic Information List
Table Octapharma Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Octapharma Human Coagulation Factor VIII Sales Market Share (2011-2016)
Table BPL Basic Information List
Table BPL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table BPL Human Coagulation Factor VIII Sales Market Share (2011-2016)
Table Kedrion Basic Information List
Table Kedrion Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kedrion Human Coagulation Factor VIII Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Coagulation Factor VIII
Figure Manufacturing Process Analysis of Human Coagulation Factor VIII
Figure Human Coagulation Factor VIII Industrial Chain Analysis
Table Raw Materials Sources of Human Coagulation Factor VIII Major Manufacturers in 2015
Table Major Buyers of Human Coagulation Factor VIII
Table Distributors/Traders List
Figure Germany Human Coagulation Factor VIII Sales and Growth Rate Forecast (2016-2021)
Figure Germany Human Coagulation Factor VIII Revenue and Growth Rate Forecast (2016-2021)
Figure France Human Coagulation Factor VIII Sales and Growth Rate Forecast (2016-2021)
Figure France Human Coagulation Factor VIII Revenue and Growth Rate Forecast (2016-2021)
Figure UK Human Coagulation Factor VIII Sales and Growth Rate Forecast (2016-2021)
Figure UK Human Coagulation Factor VIII Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Human Coagulation Factor VIII Sales and Growth Rate Forecast (2016-2021)
Figure Russia Human Coagulation Factor VIII Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Human Coagulation Factor VIII Sales and Growth Rate Forecast (2016-2021)
Figure Italy Human Coagulation Factor VIII Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Human Coagulation Factor VIII Sales and Growth Rate Forecast (2016-2021)
Figure Spain Human Coagulation Factor VIII Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Human Coagulation Factor VIII Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Human Coagulation Factor VIII Revenue and Growth Rate Forecast (2016-2021)
Table Europe Human Coagulation Factor VIII Sales Forecast by Type (2016-2021)
Table Europe Human Coagulation Factor VIII Sales Forecast by Application (2016-2021)